Skip to main content
The words approved in red capitalized letters

Aurobindo obtains FDA nod for generic Ovcon

Aurobindo's Rhuzdah is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.
Levy

The Food and Drug Administration has cleared Aurobindo’s Rhuzdah (norethindrone and ethinyl estradiol tablets), 0.4mg/0.035mg.

The medication, a generic of Warner Chilcott’s Ovcon-35 tablets, is indicated for the prevention of pregnancy in women who elect to use this product as a method of contraception.

[Read more: Aurobindo obtains FDA approval for generic Colcrys]

Rhuzdah had a market value of approximately $536,000 for the 12 months ending August 2022, according to IQVIA.

X
This ad will auto-close in 10 seconds